Literature DB >> 27089390

Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.

Han Chen1, Wang Zhidan2, Ren Xia3, Wang Zhaoxia3, Jia Qing3, Guo Qiang3, Yin Haipeng3, Wang Hengxiao4.   

Abstract

Previous studies have demonstrated that polypeptides extracted from scorpion venom (PESV) inhibited cell proliferation in several tumors, however, the effect on dysfunctional and exhausted natural killer cells which contribute to tumor escape from immune surveillance remain to be elucidated. In this study, we determined the effect of PESV on NK infiltration into H22 cells orthotopic transplantation tumors and on the expression of MHC class I chain-related proteins A (MICA) in HepG2 cells. We found that tumor growth in mice was significantly inhibited by PESV and the survival time of tumor-bearing mice treated with PESV was significantly prolonged. Moreover, levels of tumor-infiltrating NK cells, NKG2D protein, perforin and granzyme B mRNA were significantly increased in the group treated with PESV compared with the tumor-bearing control group. In addition, In addition, up-regulation of MICA by PESV enhances the susceptibility of HepG2 cells to NK lysis in vitro. These results indicate that the inhibitory effects of PESV on hepatic carcinoma are likely mediated by up-regulation of NK cell activity via the MICA-NKG2D pathway.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; MHC class I chain-related proteins A; Natural killer cells; Polypeptide; Receptor-natural killer group 2 member D; Scorpion venom

Mesh:

Substances:

Year:  2016        PMID: 27089390     DOI: 10.1016/j.intimp.2016.03.045

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

1.  Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.

Authors:  Xujun You; Yongrong Wu; Qixin Li; Wen Sheng; Qing Zhou; Wei Fu
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.

Authors:  Han Chen; Hengxiao Wang; Xiqiao Yu; Shuping Zhou; Yueying Zhang; Zhaopeng Wang; Shuhong Huang; Zhaoxia Wang
Journal:  BMC Cancer       Date:  2020-09-05       Impact factor: 4.430

Review 3.  The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.

Authors:  Sarun Juengpanich; Liang Shi; Yasaman Iranmanesh; Jiang Chen; Zhenzhe Cheng; Aaron Kah-Jin Khoo; Long Pan; Yifan Wang; Xiujun Cai
Journal:  Transl Oncol       Date:  2019-06-06       Impact factor: 4.243

4.  Anti-Cancer Activity of Buthus occitanus Venom on Hepatocellular Carcinoma in 3D Cell Culture.

Authors:  Ayoub Lafnoune; Su-Yeon Lee; Jin-Yeong Heo; Khadija Daoudi; Bouchra Darkaoui; Salma Chakir; Rachida Cadi; Khadija Mounaji; David Shum; Haeng-Ran Seo; Naoual Oukkache
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.